NasdaqGS:TYRA
NasdaqGS:TYRABiotechs

How Investors Are Reacting To Tyra Biosciences (TYRA) Bolstering Its Regulatory And Oncology Leadership

Tyra Biosciences recently strengthened its leadership team by appointing Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer, both bringing extensive oncology and regulatory experience from major biopharma companies. Their track records in securing approvals for complex medicines and launching rare oncology products could be particularly important as Tyra advances oral dabogratinib through global Phase 2 studies. With these leadership changes in place,...
NYSE:MDT
NYSE:MDTMedical Equipment

Has Medtronic’s Recent 24% Rally Left Enough Upside After Robotics and Diabetes Push?

If you are wondering whether Medtronic remains a solid value play after its recent run, or if the easy money has already been made, you are in the right place. Despite a soft patch over the last week, with the share price down around 2.3%, the stock is still up roughly 7.5% over the past month and about 24% both year to date and over the last year. That performance has investors rethinking its upside and risk profile. Recent headlines have focused on Medtronic doubling down on high growth...
NYSE:AEO
NYSE:AEOSpecialty Retail

Is It Too Late to Consider American Eagle After Its Recent 40% Share Price Surge?

Wondering if American Eagle Outfitters is still good value after its latest run, or if you are late to the party? This breakdown will walk through what the numbers are really saying about the stock. The share price has climbed to around $23.91, with gains of 14.8% over the last week, 39.8% over the past month, and more than 40% over the last year. This naturally raises questions about how much upside is left versus the risk of a pullback. Recent moves have been supported by stronger...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

Assessing Tower Semiconductor After 140% Surge and Strong Specialty Chip Demand in 2025

Wondering if Tower Semiconductor is still a buy after its huge run, or if the easy money has already been made? You are not the only one trying to figure out whether the current price reflects its real value. The stock has surged recently, up 6.9% over the last week, 26.4% over the last month, and an eye catching 140.5% year to date, with a massive 391.7% gain over the past five years reshaping expectations and risk perceptions. These moves have been helped by continuing optimism around...
NYSE:IOT
NYSE:IOTSoftware

Samsara (IOT): Rethinking Valuation After Surging Growth, New Profitability and Upgraded Outlook

Samsara (IOT) just checked several big boxes in one go, posting faster revenue growth, a move into profitability, and higher guidance that leans into strong demand for its fleet and equipment monitoring platform. See our latest analysis for Samsara. The market seems to be waking back up to that story, with a 7 day share price return of 12.25% and 90 day share price return of 13.18% even as 1 year total shareholder return is still negative. This suggests renewed momentum after a volatile...
NYSE:FLS
NYSE:FLSMachinery

Flowserve (FLS): Revisiting Valuation After D1’s Stake Increase and Strong Q3 Margin, Cash Flow Gains

D1 Capital Partners just made a big statement on Flowserve (FLS), lifting its stake to roughly 7.5 million shares after third quarter results showed better margins, stronger cash generation, and a tilt toward stickier aftermarket revenue. See our latest analysis for Flowserve. That conviction from D1 comes as Flowserve’s share price has climbed to $72.46, with a strong 90 day share price return of 27.89 percent and a powerful three year total shareholder return of 146.97 percent, suggesting...
NYSE:PDM
NYSE:PDMOffice REITs

Assessing Piedmont Realty Trust (PDM)’s Valuation After Record Leasing Momentum and Improved Asset Utilization

Piedmont Realty Trust (PDM) just reported signing more than 475,000 square feet of leases in the current quarter, pushing year to date activity to roughly 2.3 million square feet and signaling a potentially record leasing year. See our latest analysis for Piedmont Realty Trust. Even with this record leasing momentum, Piedmont’s share price, at about $8.27, still reflects a weak year to date share price return. At the same time, its three year total shareholder return remains modestly...
NYSE:BLND
NYSE:BLNDSoftware

Blend Labs (BLND) Is Up 7.4% After Doubling Down On AI Mortgage Automation And Home Equity Plans

In early December 2025, Blend Labs outlined at the Wells Fargo 9th Annual TMT Summit how it is concentrating on core software, integrating AI to speed up mortgage processing, and expanding its Rapid Suite, following a shift away from non-core operations and a move to non-GAAP operating profitability. The company also revealed plans for its new Rapid Home Equity product, which it expects will significantly increase revenue earned per loan unit, while recent insider share purchases and...
NasdaqGS:HOLX
NasdaqGS:HOLXMedical Equipment

Does The Market Underappreciate Hologic As Cash Flow Value Contrasts With Flat Long Term Returns

Wondering if Hologic is quietly becoming good value, or if the market is still sleeping on it? This breakdown will walk you through what the numbers are really saying about the stock. The share price has been relatively steady, with a 0.8% gain over the last month and a 4.4% rise year to date, but returns over 1, 3 and 5 years are roughly flat, suggesting sentiment is cautious rather than euphoric. Recently, Hologic has stayed in the spotlight as a key player in women’s health, continuing to...
NasdaqGS:PEGA
NasdaqGS:PEGASoftware

Can Pegasystems (PEGA) Moody’s-Powered KYC Upgrade Deepen Its Competitive Moat In Financial Workflows?

Pegasystems Inc. recently announced a collaboration with Moody’s Corporation, allowing Pega Client Lifecycle Management™ users to access Moody’s real-time entity verification data directly within their CLM and KYC workflows across more than 200 countries. This tie-up effectively plugs Moody’s database of over 600 million companies into Pega’s AI-powered onboarding and compliance engine, aiming to cut manual data entry errors and speed up client onboarding for global financial institutions...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

ArcBest (ARCB): Valuation Check After Expanded Credit Facility Boosts Financial Flexibility

ArcBest (ARCB) just refreshed its core revolving credit facility, extending its life to 2030 while boosting letter of credit capacity. This move quietly expands the company’s financial flexibility for the next phase of growth. See our latest analysis for ArcBest. The refreshed credit facility lands while the stock is trying to stabilize, with a recent 1 month share price return of 5.32 percent but a weak year to date share price return of 24.05 percent decline and a 1 year total shareholder...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

Playtika (PLTK) Valuation Check After Q3 Direct-to-Consumer Records and Fresh Analyst Targets

Playtika Holding (PLTK) just posted fiscal Q3 results that spotlight record direct to consumer revenue, powered by Bingo Blitz and June’s Journey, and the stock’s reaction says investors are reassessing its long term cash engine. See our latest analysis for Playtika Holding. That backdrop helps explain why, even with the share price sitting around $4.30 and a steep year to date share price return of roughly negative 38 percent plus a one year total shareholder return near negative 43 percent,...
NYSE:MKL
NYSE:MKLInsurance

Markel (MKL) Valuation Update as Underwriting Discipline, Specialty Focus and Global Expansion Reshape Its Growth Story

Markel Group (MKL) is back in the spotlight after doubling down on underwriting discipline, exiting money losing reinsurance, and leaning harder into higher margin specialty lines, all while its international footprint quietly becomes a real growth driver. See our latest analysis for Markel Group. Those moves seem to be landing well, with the share price at $2,068.26 and a strong year to date share price return of 20.43% pointing to building momentum. The five year total shareholder return of...
NYSE:HNGE
NYSE:HNGEHealthcare

Is It Too Late to Consider Hinge Health After Its Strong 2025 Share Price Rally?

If you are wondering whether Hinge Health is still worth buying at today’s price, you are not alone. The stock has quickly moved onto many investors’ watchlists and is begging for a closer look at its underlying value. After rallying about 7.5% over the last week and 11.7% over the past month, Hinge Health is now up roughly 31.7% year to date. This is the kind of move that often forces investors to ask whether the market is getting ahead of itself or finally catching up. Recent headlines...
NYSE:NOW
NYSE:NOWSoftware

ServiceNow (NOW): Has the Recent Share Price Dip Created a Valuation Opportunity?

ServiceNow (NOW) has been on a choppy ride lately, with the stock down about 19% this year even as annual revenue and net income keep growing at double digit rates. See our latest analysis for ServiceNow. Zooming out, the share price has slipped this year, but a three year total shareholder return of 104.33% shows longer term holders are still well ahead. This suggests momentum has cooled rather than vanished as investors reassess growth and valuation. If ServiceNow’s swings have you...
NYSE:RBRK
NYSE:RBRKSoftware

Rubrik (RBRK): Evaluating Valuation After a Recent 28% Weekly Share Price Jump

Rubrik (RBRK) has been on a quiet but steady climb, with the stock up about 28% over the past week and roughly 20% over the past month, catching more investors’ attention. See our latest analysis for Rubrik. Zooming out, Rubrik’s recent surge sits on top of a solid backdrop, with the year to date share price return of 37.62% and a 12 month total shareholder return of 29.66% signaling that momentum is building rather than fading around its $91.31 share price. If Rubrik’s run has you rethinking...
NasdaqGS:LOPE
NasdaqGS:LOPEConsumer Services

Grand Canyon Education (LOPE): Reassessing Valuation After Recent Share Price Pullback

Grand Canyon Education (LOPE) has been drifting lower over the past few months, with the stock down about 5% this month and roughly 26% in the past 3 months despite steady earnings growth. See our latest analysis for Grand Canyon Education. Zooming out, that recent weakness in the 1 month and 3 month share price returns sits in contrast to a still impressive 3 year and 5 year total shareholder return. This suggests long term momentum remains intact even as near term sentiment cools. If LOPE’s...
NYSE:NEM
NYSE:NEMMetals and Mining

Does Newmont’s 145% 2025 Rally Match Its Gold Fueled Earnings and Cash Flow Outlook?

If you have been wondering whether Newmont is still a buy after its big run, you are not alone. This breakdown will walk through whether the current price still stacks up against its underlying value. The stock has climbed 5.0% over the last week, 6.6% over the last month, and is up 145.2% year to date, with a 126.3% gain over the past year that has dramatically changed how the market is pricing its prospects. Recent months have seen a strong tailwind from higher gold prices and renewed...
NYSEAM:GENC
NYSEAM:GENCMachinery

Gencor Industries (GENC) Q4 EPS Slowdown Tests Bullish High-Growth Narrative

Gencor Industries (GENC) has just wrapped up FY 2025 with fourth quarter revenue of about $18.8 million and EPS of roughly $0.13, rounding out a year where trailing twelve month EPS reached $1.07 on $115.4 million of revenue. Over the past few quarters the company has seen revenue move from $20.9 million in Q4 2024 to $31.4 million, $38.2 million, $27.0 million, and then $18.8 million, while EPS shifted from $0.10 to $0.26, $0.42, $0.26, and $0.13. This gives investors a clear view of how the...
NasdaqGS:SAIL
NasdaqGS:SAILSoftware

SailPoint (SAIL) Q3 2026: Revenue Growth to $282M Tests Profitability Concerns

SailPoint (SAIL) just posted its Q3 2026 numbers, logging revenue of about $282 million with basic EPS of roughly -$0.06, while trailing twelve month figures show revenue of about $1.0 billion and basic EPS of around -$3.59. The company has seen revenue move from about $700 million on a trailing basis in late 2024 to just over $1.0 billion by Q3 2026. Over the same stretch, EPS stayed negative, keeping profitability firmly in focus for investors trying to gauge whether that top line scale can...
NasdaqGS:IDCC
NasdaqGS:IDCCSoftware

InterDigital (IDCC): Assessing Valuation After Legal Wins Boost Streaming Patent Revenue Prospects

InterDigital (IDCC) just scored a legal win that could reshape its streaming royalty stream, with courts in Germany and Brazil siding with its patents and new cases now targeting Amazon’s video technology. See our latest analysis for InterDigital. Those court wins seem to be feeding into sentiment, with InterDigital’s 1 week share price return of 6.22% and 90 day share price return of 11.76% supporting an already powerful year to date share price return of 85.17%, alongside an 88.79% 1 year...
NasdaqGS:CRSR
NasdaqGS:CRSRTech

How Corsair’s Barclays Tech Conference Spotlight May Reframe Its Long‑Term Growth Story At CRSR

Corsair Gaming recently appeared at Barclays’ 23rd Annual Global Technology Conference at The Palace Hotel in San Francisco, with CEO Thi L. La and CFO Gordon Mattingly presenting the company’s latest thinking to investors. This conference slot puts Corsair’s leadership in front of a broad institutional audience, where any commentary on product roadmap, margins, or capital allocation could influence how investors view the business over the coming quarters. We’ll now examine how investor...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

Do Analysts’ Reaffirmed Optimism Signal Durable Strength In Option Care Health’s (OPCH) Infusion Model?

In recent days, Option Care Health drew fresh attention after several major Wall Street firms reiterated positive views on the business and its long-term outlook, following management’s reaffirmation of growth objectives for revenue and earnings despite potential competitive pressures. This wave of supportive analyst commentary underscores how confidence in Option Care Health’s at-home and alternate site infusion model remains intact even as the therapy landscape evolves. Next, we’ll explore...
NYSE:PSA
NYSE:PSASpecialized REITs

Public Storage (PSA): Has the Recent 10% Pullback Opened a Quiet Value Opportunity?

Public Storage (PSA) has slid roughly 10% over the past 3 months, even as revenue and net income continue to grow. That disconnect is what has investors rethinking where this REIT fits in their portfolios. See our latest analysis for Public Storage. Zooming out, that 90 day share price return of negative 10.24 percent sits within a weaker year to date share price performance. Even so, the five year total shareholder return of 43.62 percent still shows that long term holders have been rewarded...